>글로벌 미세 침습성 녹내장 수술(MIGS) 장치 시장, 제품별(MIGS 스텐트, MIGS 션트 및 기타), 대상(섬유주망막상 맥락막상 공간 결막하 여과 및 방수 생성 감소), 수술 유형(백내장과 관련된 녹내장 및 단독 녹내장), 최종 사용자(병원 외래 환자 부서(HOPD), 안과 진료소, 외래 수술 센터 (ASCS) 및 기타), 유통 채널(직접 입찰 및 소매 판매) - 업계 동향 및 2029년까지의 예측.
미세 침습성 녹내장 수술(MIGS) 장치 시장 분석 및 규모
미세 침습성 녹내장 수술은 개방각 녹내장을 치료하는 데 사용됩니다. 처음에는 OAG를 치료하기 위해 방수 생성을 줄이거나 방수 유출을 늘리는 약물을 투여했습니다. 경증에서 중등도의 OAG의 경우 전통적으로 약물 치료와 레이저 치료를 시행했습니다. 미세 침습성 녹내장 수술(MIGS) 시술이 등장하면서 기존 수술에 적합하지 않은 사람들을 위한 새로운 옵션이 만들어졌습니다. 노인 인구가 증가하고 실명을 예방하기 위한 정부 이니셔티브가 증가함에 따라 시장이 활성화될 것으로 예상됩니다. 녹내장 약물에서 최소 침습성 녹내장 수술로의 빠른 전환은 MIGS 장치 제조업체에 기회를 창출할 수 있습니다. 그러나 환불 시설이 부족하면 시장에 장애물이 될 수 있습니다.
미세 침습 수술에 대한 수요 증가는 눈 질환의 증가, 미세 침습 수술에 대한 수요 증가, 수술적 외상 감소로 인해 예측 기간 동안 시장에 대한 수요가 증가했기 때문입니다. 그러나 높은 설치 비용과 숙련된 전문가의 부족은 예측 기간 동안 최소 침습 수술 시장 성장을 방해할 수 있습니다.
Data Bridge Market Research는 미세 침습성 녹내장 수술(MIGS) 장치 시장이 2029년까지 5,995.46백만 달러 규모에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 33.3%입니다. "MIGS 스텐트"는 미세 침습성 녹내장 수술(MIGS) 장치 사용을 상용화하기 위한 기술 경로의 빠른 발전으로 인해 미세 침습성 녹내장 수술(MIGS) 장치 시장에서 가장 큰 기술 부문을 차지합니다. 미세 침습성 녹내장 수술(MIGS) 장치 시장 보고서는 또한 심층적인 기술 발전을 다룹니다.
|
보고서 메트릭 |
세부 |
|
예측 기간 |
2022년부터 2029년까지 |
|
기준 연도 |
2021 |
|
역사적 연도 |
2020 (2019-2014까지 사용자 정의 가능) |
|
양적 단위 |
수익 (단위: USD 백만) |
|
다루는 세그먼트 |
제품별(MIGS 스텐트, MIGS 션트 및 기타), 대상(트라베큘라 메시워크 초맥락막 공간 결막하 여과 및 방수 생성 감소), 수술 유형(백내장과 관련된 녹내장 및 단독 녹내장), 최종 사용자(병원 외래 진료과(HOPD), 안과 진료소, 외래 수술 센터(ASCS) 및 기타), 유통 채널(직접 입찰 및 소매 판매) |
|
적용 국가 |
U.S., Canada, Mexico in North America. U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe in Europe. China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific in Asia-Pacific. South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Rest of Middle East and Africa (MEA) in Middle East and Africa. Brazil, Argentina and Rest of South America in South America. |
|
Market Players Covered |
AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, Microsurgical technology, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, Belkin Vision and Sight Scientific among others. |
Market Definition
MIGS stands for micro invasive glaucoma surgery, which helps treat glaucoma. It is a breakthrough technology in the treatment of mild to moderate glaucoma. It is an alternative to the medications given earlier and it also prevents the complications of conventional surgery. These procedures are used to lower the intra-ocular pressure of the eye to avoid damage to the optic nerve. These procedures are safer and have a very rapid recovery time compared to conventional surgery. The various MIGS devices implanted are shunts and stents to lower the IOP.
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics
- Increase in the geriatric population
A significant health-related issue among the elderly is vision loss. According to the American Academy of Family Physicians, by age 65, one in three people suffer from vision-reducing eye disease. The elderly population is increasing rapidly. Therefore this creates a demand for advanced technologies to treat glaucoma amongst older adults. Hence, an increase in the geriatric population is a driver for the market.
- Rise in incidence of glaucoma across the world
The cause of irreversible global blindness is majorly glaucoma. A glaucoma is a group of eye disorders that have very little to no symptoms in the initial stage but afterward lead to damage of optic nerves, which can lead to vision loss or blindness. The prevalence of glaucoma has been increasing. Therefore this creates a demand for MIGS devices; hence an increasing incidence of glaucoma is expected to act as a driver for the market.
- Government initiatives to increase awareness about the prevention of blindness
According to WHO, at least 2.2 billion people have visual impairment and blindness, out of which at least 1 billion have a vision impairment that could have been prevented. To prevent these, the government of several countries across the globe have taken initiatives. This creates a demand for advanced treatments such as micro-invasive glaucoma surgery, which boosts the MIGS device market. Hence, it is expected to act as a driver for the market.
- Introduction of technological advanced product
Glaucoma is a severe eye disease that can lead to vision loss if not controlled. It generally does not lead to blindness as it can be controlled by modern treatment and many options for preventing further damage. With the increased scientific developments, there has been a revolutionary change in the treatment of glaucoma. With the advent of micro-invasive glaucoma surgery, there is a paradigm shift in medicine as it can help in the treatment of glaucoma at an early stage and avoid the dependency on filtration surgeries like trabeculectomy. This also overcomes the risks associated with these incisional surgeries. There are various advancements in the treatment of glaucoma with MIGS.
Restraints/Challenges faced by the Market
- Stringent regulations for MIGS devices
There are at least 7 regulations that any device manufacturer must completely fulfill in the U.S., namely Establishment Registration & Medical Device Listing, Premarket Notification 510(k), Premarket Approval (PMA)(only for class three devices), Investigational Device Exemption (IDE) for clinical studies, Quality System (QS) regulation, Labeling requirements and Medical Device Reporting (MDR). These highest-risk devices need a more stringent premarket application regulatory process to demonstrate valid evidence of safety and efficacy. Lengthy timelines result in delayed access, which might restrict the market for MIGS devices.
- High cost of surgical procedures
Though glaucoma treatments have modest results and are safer than traditional filtration surgeries, they have very high costs. Also, people may require subsequent surgeries if the intra-ocular pressure is not effectively lowered at once. All these considerations make these procedures highly costly and inaccessible to most people and hence, high surgical procedure costs might be a restraint on the market.
Recent Developments
- In January 2022, Glaukos announced GLK=301's first patient enrolment in the Phase II clinical trial for dry eye disease. After the successful approval from the regulatory body, this drug will help the company grow its business segment.
- In January 2022, Alcon acquired Ivantis, developer of the novel Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device. This surgical device is designed to lower eye pressure for open-angle glaucoma patients. This acquisition will enhance the company’s portfolio in eye surgery segment.
Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope
The micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of product, target, surgery, end user and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- MIGS stents
- MIGS shunts
- Others
제품을 기준으로 보면 미세 침습성 녹내장 수술(MIGS) 장치 시장은 MIGS 션트, MIGS 스텐트 및 기타로 구분됩니다.
목표
- 트라베큘러 망사
- 초맥락막 공간
- 결막하 여과
- 수분 생산 감소
목표에 따라 미세 침습성 녹내장 수술(MIGS) 장치 시장은 트라베큘라 망사, 맥락막상 공간, 결막하 여과 및 방수 생성 감소로 구분됩니다.
수술 유형
- 백내장과 동반된 녹내장
- 단독 녹내장
수술을 기준으로 볼 때, 미세 침습성 녹내장 수술(MIGS) 장치 시장은 백내장이 동반된 녹내장과 단독 녹내장으로 구분됩니다.
최종 사용자
- 병원 외래 진료과 (HOPD)
- 안과 병원
- 외래 수술 센터(ASCS)
- 기타
최종 사용자를 기준으로 보면, 미세 침습적 녹내장 수술(MIGS) 장치 시장은 병원 외래 환자 부서(HOPD), 안과 진료소, 외래 수술 센터(ASCS) 및 기타로 구분됩니다.
유통 채널
- 직접 입찰
- 소매 판매
유통 채널을 기준으로 볼 때, 미세 침습성 녹내장 수술(MIGS) 장치 시장은 직접 입찰과 소매 판매로 구분됩니다.
미세 침습성 녹내장 수술(MIGS) 장치 시장 지역 분석/통찰력
미세 침습성 녹내장 수술(MIGS) 장치 시장을 분석하고, 위에 언급된 대로 국가, 제품, 대상, 수술, 최종 사용자 및 유통 채널별로 시장 규모에 대한 통찰력과 추세를 제공합니다.
미세 침습적 녹내장 수술(MIGS) 장치 시장 보고서에서 다루는 국가는 북미의 미국, 캐나다 및 멕시코, 유럽의 영국, 독일, 프랑스, 스페인, 이탈리아, 네덜란드, 스위스, 러시아, 벨기에, 터키 및 기타 유럽 국가, 아시아 태평양(APAC)의 중국, 한국, 일본, 인도, 호주, 싱가포르, 말레이시아, 인도네시아, 태국, 필리핀 및 기타 아시아 태평양 국가, 남아프리카, 사우디 아라비아, UAE, 이스라엘, 이집트 및 기타 중동 및 아프리카(MEA)의 일부인 중동 및 아프리카(MEA), 남미의 일부인 브라질, 아르헨티나 및 기타 남미 국가입니다.
북미는 미세 침습적 녹내장 수술(MIGS) 장치 시장을 지배하고 있습니다. 이 지역의 성장은 이 지역의 다른 안구 질환과 함께 녹내장 질환의 발병률이 증가하는 데 기인할 수 있습니다. 미국은 주요 시장 참여자의 협력 및 인수로 인해 북미 지역을 지배하고 있으며, 이는 시장 성장을 돕고 있습니다. 이 지역의 수요는 지역 제품 제공을 확장하고 확장, 파트너십 및 협력과 같은 다양한 성장 전략을 통해 신흥 시장에서 입지를 강화하는 데 중점을 두고 있는 시장 참여자에 의해 주도될 것으로 예상됩니다.
보고서의 국가 섹션은 또한 현재 및 미래 시장 추세에 영향을 미치는 개별 시장 영향 요인과 시장 규제의 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 추세 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향은 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 미세 침습성 녹내장 수술(MIGS) 장치 시장 점유율 분석
미세 침습성 녹내장 수술(MIGS) 장치 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 미세 침습성 녹내장 수술(MIGS) 장치 시장에 대한 회사의 초점과만 관련이 있습니다.
미세 침습적 녹내장 수술(MIGS) 장비 시장의 주요 기업으로는 AbbVie, BVI, Ellex, Glaukos Corporation, Johnson and Johnson, Alcon, Microsurgical technology, New World Medical, Santen Pharmaceutical, Nova Eye Medical Limited, Belkin Vision, Sight Scientific 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 INTERNATIONAL STANDARDS
4.2 REGIONAL STANDARDS
4.3 MARKET VIEWPOINT OF KEY OPINION LEADERS
4.4 EXPECTATIONS OF FUTURE MARKET SCENARIOS
4.5 FINDINGS AND REGIONAL TRENDS
4.6 COMPETITIVE GROUPING
5 COUNTRY WISE- NO OF PROCEDURES
5.1 NORTH AMERICA
5.2 EUROPE
5.3 ASIA-PACIFIC
5.4 SOUTH AMERICA
5.5 MIDDLE EAST AND AFRICA
6 REGULATION
6.1 UNITED STATES
6.2 EUROPE
6.3 CHINA
6.4 AUSTRALIA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN THE GERIATRIC POPULATION
7.1.2 RISE IN INCIDENCE OF GLAUCOMA ACROSS THE WORLD
7.1.3 GOVERNMENT INITIATIVES TO INCREASE AWARENESS ABOUT THE PREVENTION OF BLINDNESS
7.1.4 GROWTH IN POPULARITY OF MINIMALLY INVASIVE SURGERY ACROSS THE GLOBE
7.2 RESTRAINTS
7.2.1 INADEQUATE REIMBURSEMENT SCENARIO
7.2.2 STRINGENT REGULATIONS FOR MIGS DEVICES
7.2.3 HIGH COST OF SURGICAL PROCEDURES
7.3 OPPORTUNITIES
7.3.1 RAPID TRANSITION FROM GLAUCOMA MEDICATION TO MINIMALLY INVASIVE GLAUCOMA SURGERIES
7.3.2 INTRODUCTION OF TECHNOLOGICAL ADVANCED PRODUCT
7.4 CHALLENGES
7.4.1 LACK OF SKILLED PROFESSIONALS WITH ADEQUATE KNOWLEDGE
7.4.2 RISKS ASSOCIATED WITH THE MICRO INVASIVE GLAUCOMA SURGERY
8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 MIGS STENTS
8.3 MIGS SHUNTS
8.4 OTHERS
9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET
9.1 OVERVIEW
9.2 TRABECULAR MESHWORK
9.3 SUPRACHOROIDAL SPACE
9.4 SUBCONJUNCTIVAL FILTRATION
9.5 REDUCING AQUEOUS PRODUCTION
10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE
10.1 OVERVIEW
10.2 GLAUCOMA IN CONJUNCTION WITH CATARACT
10.3 STAND-ALONE GLAUCOMA
11 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITAL
11.3 OPHTHALMOLOGY CLINICS
11.4 AMBULATORY SURGERY CENTERS (ASCS)
11.5 OTHERS
12 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 U.S.
13.2.2 CANADA
13.2.3 MEXICO
13.3 EUROPE
13.3.1 GERMANY
13.3.2 FRANCE
13.3.3 U.K.
13.3.4 ITALY
13.3.5 SPAIN
13.3.6 SWITZERLAND
13.3.7 NETHERLANDS
13.3.8 BELGIUM
13.3.9 RUSSIA
13.3.10 TURKEY
13.3.11 REST OF EUROPE
13.4 ASIA-PACIFIC
13.4.1 CHINA
13.4.2 JAPAN
13.4.3 INDIA
13.4.4 SOUTH KOREA
13.4.5 AUSTRALIA
13.4.6 SINGAPORE
13.4.7 THAILAND
13.4.8 MALAYSIA
13.4.9 INDONESIA
13.4.10 PHILIPPINES
13.4.11 REST OF ASIA-PACIFIC
13.5 SOUTH AMERICA
13.5.1 BRAZIL
13.5.2 ARGENTINA
13.5.3 REST OF SOUTH AMERICA
13.6 MIDDLE EAST AND AFRICA
13.6.1 SOUTH AFRICA
13.6.2 SAUDI ARABIA
13.6.3 U.A.E.
13.6.4 ISRAEL
13.6.5 EGYPT
13.6.6 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 GLAUKOS CORPORATION
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.4.1 RECENT DEVELOPMENT
16.2 ALCON INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.4.1 RECENT DEVELOPMENTS
16.3 ABBVIE INC.
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.4.1 RECENT DEVELOPMENT
16.4 JOHNSON & JOHNSON SURGICAL VISION, INC. (A SUBSIDIARY OF JOHNSON & JOHNSON)
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.4.1 RECENT DEVELOPMENT
16.5 SANTEN PHARMACEUTICAL CO., LTD.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.4.1 RECENT DEVELOPMENTS
16.6 BELKIN VISION, ISRAEL
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 BVI
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.2.1 RECENT DEVELOPMENTS
16.8 ELLEX INC.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.2.1 RECENT DEVELOPMENTS
16.9 IOPTIMA
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.1 MICROSURGICAL TECHNOLOGY. (A SUBSIDIARY OF HALMA PLC)
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.2.1 RECENT DEVELOPMENT
16.11 NEW WORLD MEDICAL, INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.2.1 RECENT DEVELOPMENTS
16.12 NOVA EYE MEDICAL LIMITED
16.12.1 COMPANY SNAPSHOT
16.12.2 REVENUE ANALYSIS
16.12.3 PRODUCT PORTFOLIO
16.12.3.1 RECENT DEVELOPMENTS
16.13 SIGHT SCIENCES.
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT PORTFOLIO
16.13.3.1 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 NUMBER OF PEOPLE (AGED 40-80 YEARS, IN MILLIONS) WITH GLAUCOMA IN 2013 AND PROJECTION OF THE NUMBER OF PEOPLE HAVING GLAUCOMA IN 2020 AND 2040
TABLE 2 NEW OPTIONS FOR GLAUCOMA TREATMENT
TABLE 3 NUMBER OF PHYSICIANS/ THOUSAND POPULATIONS
TABLE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL MIGS STENTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL MIGS SHUNTS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL TRABECULAR MESHWORK IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL SUPRACHOROIDAL SPACE IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 GLOBAL SUBCONJUNCTIVAL FILTRATION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL REDUCING AQUEOUS PRODUCTION IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 14 GLOBAL GLAUCOMA IN CONJUNCTION WITH CATARACT IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL STAND-ALONE GLAUCOMA IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL HOSPITAL IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL OPHTHALMOLOGY CLINICS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL AMBULATORY SURGERY CENTERS (ASCS) IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL OTHERS IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL DIRECT TENDER IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL RETAIL SALES IN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 29 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 31 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 32 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 33 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 34 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 35 U.S. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 36 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 37 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 38 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 39 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 40 CANADA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 41 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 42 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 43 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 44 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 MEXICO MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 49 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 50 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 51 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 52 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 53 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 54 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 55 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 56 GERMANY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 58 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 59 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 60 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 FRANCE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 62 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 63 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 64 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 65 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 66 U.K. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 67 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 68 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 69 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 70 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 71 ITALY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 73 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 74 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 75 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 76 SPAIN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 77 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 78 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 79 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 80 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 81 SWITZERLAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 82 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 83 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 84 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 85 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 86 NETHERLANDS MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 87 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 88 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 89 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 90 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 91 BELGIUM MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 92 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 93 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 94 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 95 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 96 RUSSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 97 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 98 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 99 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 100 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 101 TURKEY MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 102 REST OF EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 103 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 104 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 105 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 106 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 107 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 108 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 109 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 110 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 111 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 112 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 113 CHINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 114 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 115 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 116 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 117 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 118 JAPAN MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 119 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 120 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 121 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 122 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 123 INDIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 124 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 125 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 126 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 127 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 128 SOUTH KOREA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 129 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 130 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 131 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 132 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 133 AUSTRALIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 134 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 135 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 136 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 137 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 138 SINGAPORE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 139 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 140 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 141 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 142 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 143 THAILAND MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 144 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 145 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 146 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 147 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 148 MALAYSIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 149 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 150 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 151 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 152 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 153 INDONESIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 154 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 155 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 156 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 157 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 158 PHILIPPINES MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 159 REST OF ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 160 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 161 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 162 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 163 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 164 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 165 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 166 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 167 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 168 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 169 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 170 BRAZIL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 171 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 172 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 173 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 174 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 175 ARGENTINA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 176 REST OF SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 177 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 178 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 179 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 180 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 181 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 182 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 183 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 184 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 185 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 186 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 187 SOUTH AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 188 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 189 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 190 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 191 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 192 SAUDI ARABIA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 193 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 194 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 195 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 196 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 197 U.A.E. MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 198 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 199 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 200 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 201 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 202 ISRAEL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 203 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
TABLE 204 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY TARGET, 2020-2029 (USD MILLION)
TABLE 205 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 206 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 207 EGYPT MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 208 REST OF MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET, BY PRODUCT, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 2 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID
FIGURE 9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET
FIGURE 14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021
FIGURE 15 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)
FIGURE 16 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, CAGR (2022-2029)
FIGURE 17 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2021
FIGURE 19 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, 2022-2029 (USD MILLION)
FIGURE 20 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, CAGR (2022-2029)
FIGURE 21 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY TARGET, LIFELINE CURVE
FIGURE 22 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2021
FIGURE 23 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, 2022-2029 (USD MILLION)
FIGURE 24 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, CAGR (2022-2029)
FIGURE 25 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 26 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2021
FIGURE 27 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 31 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 32 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 33 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 35 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2021)
FIGURE 36 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2022 & 2029)
FIGURE 37 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY REGION (2021 & 2029)
FIGURE 38 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 39 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 40 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 41 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 42 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 43 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 44 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 45 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 46 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 47 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 48 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 49 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 50 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 51 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 52 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 53 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 54 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 55 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 56 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 57 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 58 SOUTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 59 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SNAPSHOT (2021)
FIGURE 60 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021)
FIGURE 61 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 62 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 63 MIDDLE EAST AND AFRICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT (2022-2029)
FIGURE 64 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 65 NORTH AMERICA MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 66 EUROPE MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 ASIA-PACIFIC MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
